Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danhuang Longxin
- Development stage
- Unknown
- Lead developer
- Guizhou Yibai Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Danhuang Longxin (also known as Danhuang Longbi) is a Traditional Chinese Medicine (TCM) capsule developed and manufactured by Guizhou Baixiang Pharmaceutical. It is specifically indicated for the treatment of chronic prostatitis and benign prostatic hyperplasia (BPH). The formulation is composed of several herbal ingredients, including *Salvia miltiorrhiza*, *Phellodendron amurense*, and *Vaccaria segetalis*, which work synergistically to clear heat, remove dampness, and promote blood circulation. Mechanistically, the drug is thought to reduce the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), and inhibit cyclooxygenase-2 (COX-2) activity, thereby alleviating pelvic pain, urinary frequency, and urgency. It is widely used in China as a standard treatment for chronic pelvic pain syndrome (CPPS) related to prostate inflammation.
- Brand names
- Danhuang LongxinDanhuang Longbi
- Other names
- Danhuang Longbi Capsules丹黄隆闭胶囊
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Danhuang Longxin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Danhuang Longxin.